ID

34481

Descripción

SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN); ODM derived from: https://clinicaltrials.gov/show/NCT01953055

Link

https://clinicaltrials.gov/show/NCT01953055

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 22/5/19 22/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01953055

Eligibility Prostate Cancer NCT01953055

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained
Descripción

ID.1

Tipo de datos

boolean

men > 18 years of age
Descripción

ID.2

Tipo de datos

boolean

histologically confirmed prostate adenocarcinoma (centrally reviewed)
Descripción

ID.3

Tipo de datos

boolean

high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
Descripción

ID.4

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Descripción

ID.5

Tipo de datos

boolean

anticoagulation medication (if unsafe to discontinue for gold seed insertion)
Descripción

ID.6

Tipo de datos

boolean

diagnosis of bleeding diathesis
Descripción

ID.7

Tipo de datos

boolean

large prostate (>90cm3) on imaging at time of gold seed insertion
Descripción

ID.8

Tipo de datos

boolean

no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
Descripción

ID.9

Tipo de datos

boolean

definitive regional or distant metastatic disease on staging investigations
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Prostate Cancer NCT01953055

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
informed consent obtained
boolean
ID.2
Item
men > 18 years of age
boolean
ID.3
Item
histologically confirmed prostate adenocarcinoma (centrally reviewed)
boolean
ID.4
Item
high risk prostate cancer, defined as at least one of clinical stage t3 or gleason 8-10, or psa > 20ng/ml
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
prior pelvic radiotherapy
boolean
ID.6
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
ID.7
Item
diagnosis of bleeding diathesis
boolean
ID.8
Item
large prostate (>90cm3) on imaging at time of gold seed insertion
boolean
ID.9
Item
no evidence of castrate resistance (defined as psa < 3ng/ml while testosterone is < 0.7nmol/l
boolean
ID.10
Item
definitive regional or distant metastatic disease on staging investigations
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial